Home » Topics » BioWorld Science, Infection

BioWorld Science, Infection
RSS

Researchers restore front-line antibiotics' effects

Jan. 13, 2022

Novel 2-((1H-indol-3-yl)thio)-N-phenyl-acetamides as inhibitors of SARS-CoV-2 RdRp

Jan. 13, 2022

Development of haloperidol analogues as Eis inhibitors to overcome kanamycin resistance in MDR TB

Jan. 13, 2022

REVTx-99 demonstrates in vitro antiviral activity against SARS-CoV-2

Jan. 12, 2022

Discovery of novel hybrid compounds as antitubercular agents

Jan. 12, 2022

AC Immune synthesizes NLRP3 inflammasome inhibitors

Jan. 11, 2022

Immunization with MERS-CoV RNA replicons proves to be safe and effective in mice

Jan. 11, 2022

Identification of novel drug candidates targeting dengue virus capsid protein

Jan. 10, 2022

RBT-0813 shown to neutralize Omicron and Delta variants of SARS-CoV-2 in live virus studies

Jan. 7, 2022

French researchers patent new antibacterial compounds

Jan. 7, 2022

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for July 1, 2026.
News in brief
BioWorld Asia
BioWorld Asia briefs for June 30, 2026
CINP 2026: Gut microbiota could predict antidepressant response
BioWorld
The gut microbiota may be altered in people with depression as a result of treatment. These microorganisms reorganize differently in individuals who respond to...
Ascending BCI systems deepen national security, ethical concerns
BioWorld
Ready or not, the future has arrived. Novel AI and brain-computer interface (BCI) systems are no longer confined to the realm of science fiction. As an...
Deep brain stimulation from the shallows: tomorrow’s BCI technology?
BioWorld
Deep brain stimulation (DBS) through implanted electrodes has enabled fundamentally new ways of treating certain disorders. More than 100,000 severely ill...